GlassScriptPhysician profile
Samuel E Scroggins
NPI 1487742375
$2,391.10
in general payments reported to CMS, 2019-2025
11 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2021: $1,593 · 2022: $13.72 · 2023: $123 · 2024: $261 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361 · Entertainment: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.29 |
| Entertainment | $217.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,179.98 | 2021 | |
| Keystone Dental INC. | $384.66 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $236.00 | 2019-2021 | |
| Depuy Synthes Sales INC. | $221.26 | 2021 | |
| Stryker Corporation | $179.52 | 2025 | Na, Vsp System, Vsp Cranial |
| Nobel Biocare USA | $58.89 | 2019-2021 | |
| Salvin Dental Specialties, INC. | $48.75 | 2021 | |
| Biohorizons Implant Systems INC. | $39.67 | 2023-2024 | Biohorizons |
| Henry Schein, INC. | $15.73 | 2025 | Nuoss, Allooss Allograft Putty, Ace Surgical Supply |
| Kowa Pharmaceuticals America, INC. | $13.72 | 2022 | |
| Biolase, INC. | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Scroggins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.